NCT01729962

Brief Summary

The primary purpose of this comparative clinical study is to collect clinical data to demonstrate the equivalence of the investigational device to the predicate device for measurements of the eye. The secondary purpose is to evaluate any adverse events that occur during the clinical study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2012

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 21, 2012

Completed
10 days until next milestone

Study Start

First participant enrolled

December 1, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

June 28, 2013

Status Verified

June 1, 2013

Enrollment Period

4 months

First QC Date

November 7, 2012

Last Update Submit

June 26, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Agreement and Precision Endpoints Analyses

    The agreement of the Nidek optical biometer with the predicate device will be assessed for the following measures: * Axial Length; * Keratometry; * Corneal Cylinder Axis; * Anterior Chamber Depth; * Central Corneal Thickness; * White-to-White Distance; and * Pupil Diameter. In addition, the agreement of the Nidek optical biometer with the ultrasound reference device will be assessed for axial length and anterior chamber depth. The precision of Nidek optical biometer and the predicate device will be assessed for the following measures: * Axial Length; * Keratometry; * Corneal Cylinder Axis; * Anterior Chamber Depth; * Central Corneal Thickness; * White-to-White Distance; and * Pupil Diameter.

    Subjects will be followed for the duration of the procedure, up to one day.

Secondary Outcomes (1)

  • Evaluation of Adverse Events Found During the Study

    Subjects will be followed for the duration of the procedure, up to one day.

Other Outcomes (1)

  • Additional Analyses for the Agreement Portion of the Study

    Subjects will be followed for the duration of the procedure, up to one day.

Study Arms (2)

Agreement Cohort

All subjects in the agreement portion of the study will have a single measurement performed with each device, the Nidek optical biometer, predicate device and ultrasound reference device. Each device will be operated by a different operator.

Precision Cohort

All subjects in the precision portion of the study will each be paired with one Nidek optical biometer and with one predicate device for a total of three Nidek optical biometer/predicate device pairs. Each of the three device pairs will be designated one and only one operator. All subjects in the precision portion of the study will have their measurements repeated three times on each of three Nidek optical biometer and predicate device pairs.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Normal eyes(phakic eyes without cataracts or corneal disease), eyes with cataracts, eyes without a natural lens (including aphakic and pseudophakic eyes), eyes with corneal disease (including eyes post keratorefractive surgery).

You may qualify if:

  • Subjects who can follow the instructions by the Principal/Clinical Investigator or clinical staff at the clinical site, and can visit on scheduled examination dates.
  • Subjects who sign an informed consent form to participate in the clinical trial.
  • Subjects who agree to take the qualifying eye examination and a series of devices measurements.
  • Subjects able to fixate on a target.
  • Subjects must meet at lease one of the following criteria:
  • Normal eyes: Subjects with a natural lens without a cataract, corneal abnormalities or prior keratorefractive surgery.
  • Eyes with Cataracts: Subjects with a pre-existing cataract without corneal abnormalities or prior keratorefractive surgery.
  • Eyes without a Natural Lens: Subjects that are pseudophakic or aphakic without corneal abnormalities or prior keratorefractive surgery.
  • Eyes with Corneal Abnormality: Subjects with a corneal abnormality and a natural lens without a cataract, or Subjects post keratorefractive surgery and a natural lens without a cataract.

You may not qualify if:

  • Pregnancy.
  • Any eye condition preventing use of any of the instruments used in the study.
  • Any eye condition which might impair the validity of results from any of the instruments used in the study.
  • Any medical condition, which, in the Investigator's judgment, interferes with the subject's ability to comply with the protocol, compromises subject safety, or interferes with the interpretation of the study results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physicians Protocol

Greensboro, North Carolina, 27410-2548, United States

Location

MeSH Terms

Conditions

CataractAphakia

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Karl G Stonecipher, M.D.

    Physicians Protocol

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2012

First Posted

November 21, 2012

Study Start

December 1, 2012

Primary Completion

April 1, 2013

Study Completion

May 1, 2013

Last Updated

June 28, 2013

Record last verified: 2013-06

Locations